anti-Mullerian hormone
| GO Term | Evidence Code | PMID |
|---|---|---|
| ovarian follicle development |
|
|
| ovarian follicle development |
|
|
| preantral ovarian follicle growth |
|
|
| urogenital system development |
|
|
| Mullerian duct regression |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| signaling receptor binding |
|
|
| signaling receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
| Gene Ontology |
|---|
| Mullerian duct regression |
| gonad development |
| gonadal mesoderm development |
| growth factor activity |
| Location | References |
|---|---|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026